← All companies

EMED Technologies

Healthcare & Life Sci

Company overview

EMED Technologies designs and manufactures drug delivery systems for subcutaneous infusion, and was founded in 1991. Its Tetra device and SCIg60 System deliver subcutaneous immunoglobulin therapy. VersaRate is a line of flow regulators, and AccuSert and SAF-Q are specialized needle sets, both used in infusion therapy.

EMED Technologies raised $8 million in venture funding in February 2026. EMED Technologies is an H-1B sponsor.

Industry
Healthcare & Life Sci
Headquarters
United States

Filters

Create your account

Create an account to save jobs and track applications.